Format
Sort by

Send to

Choose Destination

Search Tip

Sort by Best Match to display results from highest to lowest relevance to your search terms.

Try it Now

Search results

Items: 1 to 20 of 216

  • Unknown sort schema '{last_sort_schema}' ignored
  • The following term was not found in PubMed: KL%5BAuthor%5D.
1.

Transplant Center Volume and the Risk of Pancreas Allograft Failure.

Alhamad T, Malone AF, Brennan DC, Stratta RJ, Chang SH, Wellen JR, Horwedel TA, Lentine KL.

Transplantation. 2017 Jan 17. doi: 10.1097/TP.0000000000001628. [Epub ahead of print]

PMID:
28099402
2.

OPTN/SRTR 2015 Annual Data Report: Economics.

Schnitzler MA, Skeans MA, Axelrod DA, Lentine KL, Randall HB, Snyder JJ, Israni AK, Kasiske BL.

Am J Transplant. 2017 Jan;17 Suppl 1:425-502. doi: 10.1111/ajt.14130.

PMID:
28052600
3.

Survival implications of opioid use before and after liver transplantation.

Randall HB, Alhamad T, Schnitzler MA, Zhang Z, Ford-Glanton S, Axelrod DA, Segev DL, Kasiske BL, Hess GP, Yuan H, Ouseph R, Lentine KL.

Liver Transpl. 2017 Mar;23(3):305-314. doi: 10.1002/lt.24714.

PMID:
28027603
4.

Compact silicon photonic resonance-sssisted variable optical attenuator.

Wang X, Aguinaldo R, Lentine A, DeRose C, Starbuck AL, Trotter D, Pomerene A, Mookherjea S.

Opt Express. 2016 Nov 28;24(24):27600-27613. doi: 10.1364/OE.24.027600.

PMID:
27906331
5.

Wide-range and fast thermally-tunable silicon photonic microring resonators using the junction field effect.

Wang X, Lentine A, DeRose C, Starbuck AL, Trotter D, Pomerene A, Mookherjea S.

Opt Express. 2016 Oct 3;24(20):23081-23093. doi: 10.1364/OE.24.023081.

PMID:
27828374
6.

Differential risks for adverse outcomes 3 years after kidney transplantation based on initial immunosuppression regimen: a national study.

Dharnidharka VR, Schnitzler MA, Chen J, Brennan DC, Axelrod D, Segev DL, Schechtman KB, Zheng J, Lentine KL.

Transpl Int. 2016 Nov;29(11):1226-1236. doi: 10.1111/tri.12850.

PMID:
27564782
7.

Understanding and Communicating Medical Risks for Living Kidney Donors: A Matter of Perspective.

Lentine KL, Segev DL.

J Am Soc Nephrol. 2017 Jan;28(1):12-24. doi: 10.1681/ASN.2016050571.

PMID:
27591246
8.

Predonation Prescription Opioid Use: A Novel Risk Factor for Readmission After Living Kidney Donation.

Lentine KL, Lam NN, Schnitzler MA, Hess GP, Kasiske BL, Xiao H, Axelrod D, Garg AX, Schold JD, Randall H, Dzebisashvili N, Brennan DC, Segev DL.

Am J Transplant. 2016 Sep 2. doi: 10.1111/ajt.14033. [Epub ahead of print]

PMID:
27589826
9.

The Changing Financial Landscape of Renal Transplant Practice: A National Cohort Analysis.

Axelrod DA, Schnitzler MA, Xiao H, Naik AS, Segev DL, Dharnidharka VR, Brennan DC, Lentine KL.

Am J Transplant. 2017 Feb;17(2):377-389. doi: 10.1111/ajt.14018.

PMID:
27565133
10.

High performance waveguide-coupled Ge-on-Si linear mode avalanche photodiodes.

Martinez NJ, Derose CT, Brock RW, Starbuck AL, Pomerene AT, Lentine AL, Trotter DC, Davids PS.

Opt Express. 2016 Aug 22;24(17):19072-81. doi: 10.1364/OE.24.019072.

PMID:
27557187
11.

Clinical and Economic Consequences of Early Cancer after Kidney Transplantation in Contemporary Practice.

Dharnidharka VR, Naik AS, Axelrod D, Schnitzler MA, Xiao H, Brennan DC, Segev DL, Randall H, Chen J, Kasiske B, Lentine KL.

Transplantation. 2016 Aug 3. [Epub ahead of print]

PMID:
27490413
12.

Diabetes Mellitus in Living Pancreas Donors: Use of Integrated National Registry and Pharmacy Claims Data to Characterize Donation-Related Health Outcomes.

Lam NN, Schnitzler MA, Segev DL, Hess GP, Kasiske BL, Randall HB, Axelrod D, Xiao H, Garg AX, Brennan DC, Lentine KL.

Transplantation. 2016 Aug 1. [Epub ahead of print]

PMID:
27482962
13.

Selected Mildly Obese Donors Can Be Used Safely in Simultaneous Pancreas and Kidney Transplantation.

Alhamad T, Malone AF, Lentine KL, Brennan DC, Wellen J, Chang SH, Chakkera HA.

Transplantation. 2016 Jul 15. [Epub ahead of print]

PMID:
27428713
14.

Patterns of End-Stage Renal Disease Caused by Diabetes, Hypertension, and Glomerulonephritis in Live Kidney Donors.

Anjum S, Muzaale AD, Massie AB, Bae S, Luo X, Grams ME, Lentine KL, Garg AX, Segev DL.

Am J Transplant. 2016 Jun 11. doi: 10.1111/ajt.13917. [Epub ahead of print]

PMID:
27287605
15.

Improving Access to Liver Care Across the Continuum of Care: Opportunities and Challenges.

Axelrod DA, Lentine KL.

Am J Transplant. 2016 Jun 6. doi: 10.1111/ajt.13903. [Epub ahead of print] No abstract available.

PMID:
27265241
16.

Kidney-Failure Risk Projection for the Living Kidney-Donor Candidate.

Grams ME, Garg AX, Lentine KL.

N Engl J Med. 2016 May 26;374(21):2094-5. doi: 10.1056/NEJMc1603007. No abstract available.

17.

Recipient Outcomes Following Transplantation of Allografts From Live Kidney Donors Who Subsequently Developed End-Stage Renal Disease.

Muzaale AD, Massie AB, Anjum S, Liao C, Garg AX, Lentine KL, Segev DL.

Am J Transplant. 2016 May 12. doi: 10.1111/ajt.13869. [Epub ahead of print]

PMID:
27172445
18.

The Risk of Cardiovascular Disease Is Not Increasing Over Time Despite Aging and Higher Comorbidity Burden of Kidney Transplant Recipients.

Lam NN, Kim SJ, Knoll GA, McArthur E, Lentine KL, Naylor KL, Li AH, Shariff SZ, Ribic CM, Garg AX.

Transplantation. 2017 Mar;101(3):588-596. doi: 10.1097/TP.0000000000001155.

PMID:
26985745
19.

Evaluation and Management of Pulmonary Hypertension in Kidney Transplant Candidates and Recipients: Concepts and Controversies.

Lentine KL, Villines TC, Axelrod D, Kaviratne S, Weir MR, Costa SP.

Transplantation. 2017 Jan;101(1):166-181. doi: 10.1097/TP.0000000000001043.

PMID:
26985742
20.

Pretransplant Midodrine Use: A Newly Identified Risk Marker for Complications After Kidney Transplantation.

Alhamad T, Brennan DC, Brifkani Z, Xiao H, Schnitzler MA, Dharnidharka VR, Axelrod D, Segev DL, Lentine KL.

Transplantation. 2016 May;100(5):1086-93. doi: 10.1097/TP.0000000000001113.

PMID:
26950718
Items per page

Supplemental Content

Loading ...
Support Center